Long-term outcomes in dogs with sinonasal aspergillosis treated with intranasal infusions of enilconazole.

Schuller, Simone; Clercx, Cecile (2007). Long-term outcomes in dogs with sinonasal aspergillosis treated with intranasal infusions of enilconazole. Journal of the American Animal Hospital Association, 43(1), pp. 33-38. American Animal Hospital Association 10.5326/0430033

Full text not available from this repository. (Request a copy)

Long-term outcomes (mean 38+/-17 months) were evaluated in 27 dogs with sinonasal aspergillosis after successful medical treatment using intranasal infusions of 1% or 2% enilconazole (1%, n=15; 2%, n=12). Long-term outcomes with both treatment protocols were good, with half of the dogs being asymptomatic throughout the follow-up period. The remaining dogs showed mild clinical signs compatible with chronic rhinitis/sinusitis. These clinical signs were interpreted as chronic lymphoplasmacytic rhinitis/sinusitis and episodes of bacterial rather than fungal infection. Three dogs had confirmed reinfection or relapse 2 to 36 months after clinical resolution.

Item Type:

Journal Article (Original Article)

Division/Institute:

05 Veterinary Medicine > Department of Clinical Veterinary Medicine (DKV) > Small Animal Clinic > Small Animal Clinic, Internal Medicine

UniBE Contributor:

Schuller, Simone

Subjects:

600 Technology > 630 Agriculture
600 Technology > 610 Medicine & health

ISSN:

0587-2871

Publisher:

American Animal Hospital Association

Language:

English

Submitter:

Simone Schuller

Date Deposited:

10 Oct 2014 10:34

Last Modified:

10 Oct 2014 10:34

Publisher DOI:

10.5326/0430033

PubMed ID:

17209083

URI:

https://boris.unibe.ch/id/eprint/59116

Actions (login required)

Edit item Edit item
Provide Feedback